Capsida Biotherapeutics is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders.
Capsida Biotherapeutics's investors include AbbVie, Versant Ventures, Westlake Village BioPartners.
Capsida Biotherapeutics is headquartered in Newbury Park, United States.
Capsida Biotherapeutics is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders.
Capsida Biotherapeutics is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Capsida Biotherapeutics — Funding & Investors." VCBacked, February 23, 2023, https://www.vcbacked.co/company/capsida-biotherapeutics. Accessed September 30, 2026.
VCBacked. (2023). Capsida Biotherapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/capsida-biotherapeutics
{{cite web |title=Capsida Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/capsida-biotherapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated